PharmaCorp Rx Inc. PCRX.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 16.91M | 16.75M | 18.88M | 3.61M | 7.01M |
| Total Receivables | 1.12M | 848.60K | 888.30K | 564.20K | 471.60K |
| Inventory | 2.20M | 2.19M | 1.97M | 1.77M | 1.24M |
| Prepaid Expenses | 97.00K | 67.20K | 59.00K | 135.10K | 41.40K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 20.33M | 19.85M | 21.80M | 6.08M | 8.77M |
|
|
|||||
| Total Current Assets | 20.33M | 19.85M | 21.80M | 6.08M | 8.77M |
| Net Property, Plant & Equipment | 3.80M | 3.90M | 4.00M | 3.04M | 2.90M |
| Long-term Investments | 13.11M | 13.33M | 13.57M | 10.07M | 9.18M |
| Goodwill | 13.11M | 13.33M | 13.57M | 10.07M | 9.18M |
| Total Other Intangibles | 8.07M | 8.14M | 8.46M | 5.71M | 3.55M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | 1.53M |
| Total Assets | 45.31M | 45.23M | 47.82M | 28.51M | 25.93M |
|
|
|||||
| Total Accounts Payable | 2.38M | 1.71M | 3.79M | 2.04M | 1.44M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 383.30K | 387.40K | 397.10K | 354.10K | 111.20K |
| Total Finance Division Other Current Liabilities | -- | 14.50K | 45.60K | 7.90K | 15.20K |
| Total Other Current Liabilities | -- | 14.50K | 45.60K | 7.90K | 15.20K |
| Total Current Liabilities | 2.76M | 2.11M | 4.24M | 2.40M | 1.57M |
|
|
|||||
| Total Current Liabilities | 2.76M | 2.11M | 4.24M | 2.40M | 1.57M |
| Long-Term Debt | 2.15M | 2.20M | 2.25M | 2.26M | 205.70K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 585.70K | 619.90K | 664.90K | 488.10K | 327.60K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.37M | 2.46M | 2.55M | 1.67M | 1.52M |
| Total Liabilities | 7.87M | 7.38M | 9.70M | 6.82M | 3.62M |
|
|
|||||
| Common Stock & APIC | 37.33M | 37.98M | 38.62M | 23.39M | 23.73M |
| Retained Earnings | -1.65M | -1.95M | -2.29M | -1.86M | -1.59M |
| Treasury Stock & Other | 1.48M | 1.51M | 1.54M | -- | -- |
| Total Common Equity | 37.16M | 37.54M | 37.87M | 21.52M | 22.14M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 37.16M | 37.54M | 37.87M | 21.52M | 22.14M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 277.00K | 309.30K | 253.80K | 167.50K | 171.00K |
| Total Equity | 37.44M | 37.85M | 38.12M | 21.69M | 22.32M |
|
|
|||||